FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948565764> ?p ?o ?g. }

• W2948565764 endingPage "1340" @default.
• W2948565764 startingPage "1331" @default.
• W2948565764 abstract "Immune checkpoint inhibitors (ICIs) have revolutionized oncology, but are associated with immune-related adverse events. Clinically, pneumonitis is a well-recognized complication, but its histopathologic features are poorly understood. Institutional archives were searched for patients having ICI therapy and subsequent lung tissue sampling. After excluding infectious cases, 9 patients (5 women, median: 59 y) were identified with clinically suspected ICI-related pneumonitis. Clinical history, imaging, and pathology slides were reviewed. Patients received pembrolizumab (6 cases), nivolumab (1), ipilimumab followed by pembrolizumab (1), or pembrolizumab followed by nivolumab (1); the latter experienced pneumonitis with both agents. Treatment duration ranged from 1 to 33 cycles (median: 8). Three patients received concurrent chemotherapy and 1 received radiation; the remainder received ICI monotherapy. Symptoms were nonspecific; 2 patients were asymptomatic. Thoracic imaging showed bilateral ground glass or nodular opacities in all cases, often with pleural effusion. Histologically, organizing pneumonia was seen in 7 patients, all with subclinical or mild disease, admixed with vague non-necrotizing airspace granulomas in 3 cases; all 6 patients with follow-up did well. One patient had acute fibrinous pneumonitis and 1 had diffuse alveolar damage; both died. All 9 cases showed foamy macrophages and pneumocyte vacuolization; 6 had rare eosinophils. ICI-related pneumonitis presents as bilateral ground-glass opacities or nodules, and usually manifests as organizing pneumonia histopathologically, often with vague non-necrotizing airspace granulomas. Foamy macrophages and pneumocyte vacuolization are characteristic and rare eosinophils are often seen. Less commonly, acute fibrinous pneumonitis or diffuse alveolar damage can occur, which may be fatal." @default.
• W2948565764 created "2019-06-14" @default.
• W2948565764 creator A5029859964 @default.
• W2948565764 creator A5034226178 @default.
• W2948565764 creator A5041377489 @default.
• W2948565764 creator A5041759077 @default.
• W2948565764 creator A5041817739 @default.
• W2948565764 creator A5055504335 @default.
• W2948565764 date "2019-10-01" @default.
• W2948565764 modified "2023-09-29" @default.
• W2948565764 title "Clinical and Histopathologic Features of Immune Checkpoint Inhibitor-related Pneumonitis" @default.
• W2948565764 cites W2000052892 @default.
• W2948565764 cites W2001136531 @default.
• W2948565764 cites W2104347254 @default.
• W2948565764 cites W2301851804 @default.
• W2948565764 cites W2487303921 @default.
• W2948565764 cites W2508205285 @default.
• W2948565764 cites W2522337762 @default.
• W2948565764 cites W2525217971 @default.
• W2948565764 cites W2593554932 @default.
• W2948565764 cites W2594042408 @default.
• W2948565764 cites W2608140135 @default.
• W2948565764 cites W2745126191 @default.
• W2948565764 cites W2745307296 @default.
• W2948565764 cites W2781601010 @default.
• W2948565764 cites W2783137027 @default.
• W2948565764 cites W2790068003 @default.
• W2948565764 cites W2791567488 @default.
• W2948565764 cites W2889043644 @default.
• W2948565764 cites W2891486030 @default.
• W2948565764 cites W2893321040 @default.
• W2948565764 cites W2898254759 @default.
• W2948565764 cites W2901198372 @default.
• W2948565764 cites W2902441602 @default.
• W2948565764 cites W2903585288 @default.
• W2948565764 cites W2915824683 @default.
• W2948565764 cites W4246107242 @default.
• W2948565764 cites W81164926 @default.
• W2948565764 doi "https://doi.org/10.1097/pas.0000000000001298" @default.
• W2948565764 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31162288" @default.
• W2948565764 hasPublicationYear "2019" @default.
• W2948565764 type Work @default.
• W2948565764 sameAs 2948565764 @default.
• W2948565764 citedByCount "45" @default.
• W2948565764 countsByYear W29485657642019 @default.
• W2948565764 countsByYear W29485657642020 @default.
• W2948565764 countsByYear W29485657642021 @default.
• W2948565764 countsByYear W29485657642022 @default.
• W2948565764 countsByYear W29485657642023 @default.
• W2948565764 crossrefType "journal-article" @default.
• W2948565764 hasAuthorship W2948565764A5029859964 @default.
• W2948565764 hasAuthorship W2948565764A5034226178 @default.
• W2948565764 hasAuthorship W2948565764A5041377489 @default.
• W2948565764 hasAuthorship W2948565764A5041759077 @default.
• W2948565764 hasAuthorship W2948565764A5041817739 @default.
• W2948565764 hasAuthorship W2948565764A5055504335 @default.
• W2948565764 hasConcept C121608353 @default.
• W2948565764 hasConcept C126322002 @default.
• W2948565764 hasConcept C126838900 @default.
• W2948565764 hasConcept C142724271 @default.
• W2948565764 hasConcept C2777134676 @default.
• W2948565764 hasConcept C2777701055 @default.
• W2948565764 hasConcept C2777714996 @default.
• W2948565764 hasConcept C2777910003 @default.
• W2948565764 hasConcept C2777914695 @default.
• W2948565764 hasConcept C2779524853 @default.
• W2948565764 hasConcept C2779634585 @default.
• W2948565764 hasConcept C2780030458 @default.
• W2948565764 hasConcept C2780057760 @default.
• W2948565764 hasConcept C2909621147 @default.
• W2948565764 hasConcept C2910746656 @default.
• W2948565764 hasConcept C71924100 @default.
• W2948565764 hasConcept C9418649 @default.
• W2948565764 hasConceptScore W2948565764C121608353 @default.
• W2948565764 hasConceptScore W2948565764C126322002 @default.
• W2948565764 hasConceptScore W2948565764C126838900 @default.
• W2948565764 hasConceptScore W2948565764C142724271 @default.
• W2948565764 hasConceptScore W2948565764C2777134676 @default.
• W2948565764 hasConceptScore W2948565764C2777701055 @default.
• W2948565764 hasConceptScore W2948565764C2777714996 @default.
• W2948565764 hasConceptScore W2948565764C2777910003 @default.
• W2948565764 hasConceptScore W2948565764C2777914695 @default.
• W2948565764 hasConceptScore W2948565764C2779524853 @default.
• W2948565764 hasConceptScore W2948565764C2779634585 @default.
• W2948565764 hasConceptScore W2948565764C2780030458 @default.
• W2948565764 hasConceptScore W2948565764C2780057760 @default.
• W2948565764 hasConceptScore W2948565764C2909621147 @default.
• W2948565764 hasConceptScore W2948565764C2910746656 @default.
• W2948565764 hasConceptScore W2948565764C71924100 @default.
• W2948565764 hasConceptScore W2948565764C9418649 @default.
• W2948565764 hasIssue "10" @default.
• W2948565764 hasLocation W29485657641 @default.
• W2948565764 hasLocation W29485657642 @default.
• W2948565764 hasOpenAccess W2948565764 @default.
• W2948565764 hasPrimaryLocation W29485657641 @default.
• W2948565764 hasRelatedWork W1984048268 @default.
• W2948565764 hasRelatedWork W2508205285 @default.
• W2948565764 hasRelatedWork W2611760803 @default.

• next